COVID-19 pandemic
The Korea Disease Control and Prevention Agency extends the use of the Oxford-AstraZeneca vaccine to people aged 65 and older as overseas trials show its effectiveness.
Sources: The Korea Herald
Changes
- The Korea Disease Control and Prevention Agency extends the use of Oxford-AstraZeneca vaccine to people aged 65 and older as overseas trials show its effectiveness.
- The Korea Disease Control and Prevention Agency extends the use of the Oxford-AstraZeneca vaccine to people aged 65 and older as overseas trials show its effectiveness.